Nefopam is a centrally acting, non-opioid analgesic belonging to the benzoxazocine class, which is primarily indicated for the management of moderate to severe pain, including postoperative, dental, joint,… Read more














Nefopam is a centrally acting, non-opioid analgesic belonging to the benzoxazocine class, which is primarily indicated for the management of moderate to severe pain, including postoperative, dental, joint, muscle, and cancer-related conditions. To ensure the quality, safety, and efficacy of this medication, laboratories utilize a comprehensive range of related compounds, including pharmaceutical reference standards, known process impurities, and degradation products. Stable isotope labelled compounds, such as deuterated analogues, are also essential tools, serving as internal standards in mass spectrometry-based assays to enhance accuracy during bioanalysis. These materials support critical pharmaceutical activities, such as impurity profiling, the validation of analytical methods, and routine quality control testing. By providing materials that track metabolites like N-desmethyl nefopam and glucuronide conjugates, this collection enables precise monitoring of drug metabolism and ensures compliance with regulatory standards throughout the drug development lifecycle.